We are live on
!
Find out more
Anika Therapeutics
ANIK
ANIK
130 hedge funds and large institutions have $179M invested in Anika Therapeutics in 2026 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 49 increasing their positions, 41 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
9,133% more call options, than puts
Call options by funds: $277K | Put options by funds: $3K
52% more capital invested
Capital invested by funds: $118M → $179M (+$61.3M)
41% more first-time investments, than exits
New positions opened: 24 | Existing positions closed: 17
20% more repeat investments, than reductions
Existing positions increased: 49 | Existing positions reduced: 41
7.23% more ownership
Funds ownership: 85% → 92.22% (+7.2%)
3% more funds holding
Funds holding: 126 → 130 (+4)
Holders
130
Holders Change
+4
Holders Change %
+3.17%
% of All Funds
1.6%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
24
Increased
49
Reduced
41
Closed
17
Calls
$277K
Puts
$3K
Net Calls
+$274K
Net Calls Change
+$240K
Top Buyers
| 1 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$3.16M |
| 2 |
AQR Capital Management
Greenwich,
Connecticut
|
+$2.36M |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$1.21M |
| 4 |
Morgan Stanley
New York
|
+$1.16M |
| 5 |
JFG
Jefferies Financial Group
New York
|
+$1.09M |
Top Sellers
| 1 |
TI
Trigran Investments
Northbrook,
Illinois
|
-$1.62M |
| 2 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$1.17M |
| 3 |
Jane Street
New York
|
-$933K |
| 4 |
D.E. Shaw & Co
New York
|
-$791K |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$734K |
